Prostate Disease

Two-fractionated stereotactic magnetic resonance-guided adaptive radiation therapy for patients with prostate cancer (SMART PRO trial): protocol for a confirmatory clinical trial
Sadamoto Zenda, Tairo Kashihara, Tetsuo Saito, Hiroyuki Okamoto, Noriyuki Kadoya, Takahiro Chiba, Shin-ei Noda, Takashi Kawaguchi, Keiichi Jingu, Keiko Shibuya, Takashi Uno, Hiroshi Igaki

BMJ Open Aug 2024, 14 (8) e082899; DOI: 10.1136/bmjopen-2023-082899
Electroacupuncture for lower urinary tract symptoms in men with benign prostatic hyperplasia: study protocol for a randomised controlled trial
Lili Zhu, Yan Yan, Jinna Yu, Yan Liu, Yuanjie Sun, Yu Chen, Jiufei Fang, Zhishun Liu

BMJ Open Jul 2024, 14 (7) e080743; DOI: 10.1136/bmjopen-2023-080743
Association between immune-inflammatory indexes and lower urinary tract symptoms: an analysis of cross-sectional data from the US National Health and Nutrition Examination Survey (2005–2008)
Wen Liu, Jia Wang, Miaomiao Wang, Xin Ding, Miao Wang, Ming Liu

BMJ Open Mar 2024, 14 (3) e080826; DOI: 10.1136/bmjopen-2023-080826
Retrospective cohort study of androgen deprivation therapy and the risk of diabetes in men with prostate cancer in Lithuania
Mingaile Drevinskaite, Ausvydas Patasius, Marius Kincius, Vincas Urbonas, Giedre Smailyte

BMJ Open Jul 2021, 11 (7) e045797; DOI: 10.1136/bmjopen-2020-045797
Reirradiation Options for Previously Irradiated Prostate cancer (RO-PIP): Feasibility study investigating toxicity outcomes following reirradiation with stereotactic body radiotherapy (SBRT) versus high-dose-rate brachytherapy (HDR-BT)
Jim Zhong, Sarah Brown, Maria Serra, Pam Shuttleworth, Peter Bownes, Christopher Thompson, Rachel Reed, Kimberley Reeves, Michael Dubec, Damien McHugh, Cynthia Eccles, Robert Chuter, Yat Man Tsang, N Jane Taylor, Catharine West, David Buckley, Andrew Scarsbrook, Ananya Choudhury, Peter Hoskin, Ann Henry

BMJ Open Nov 2022, 12 (11) e068580; DOI: 10.1136/bmjopen-2022-068580
Prostate MRI versus PSA screening for prostate cancer detection (the MVP Study): a randomised clinical trial
Robert Nam, Chirag Patel, Laurent Milot, Amanda Hird, Christopher Wallis, Patrick Macinnis, Mala Singh, Urban Emmenegger, Christopher Sherman, Masoom A Haider

BMJ Open Nov 2022, 12 (11) e059482; DOI: 10.1136/bmjopen-2021-059482
Retrospective analysis to describe trends in first-ever prostate-specific antigen (PSA) testing for primary healthcare facilities in the Gauteng Province, South Africa, between 2006 and 2016
Naseem Cassim, Timothy R Rebbeck, Deborah K Glencross, Jaya A George

BMJ Open Mar 2022, 12 (3) e050646; DOI: 10.1136/bmjopen-2021-050646
Moving forward through consensus: a national Delphi approach to determine the top research priorities in prostate cancer in Uganda
Andrew Sentoogo Ssemata, Richard Muhumuza, Janet Seeley, Dorothy Chilambe Lombe, Monde Mwamba, Susan Msadabwe, Amos Deogratius Mwaka, Ajay Aggarwal

BMJ Open Nov 2023, 13 (11) e075739; DOI: 10.1136/bmjopen-2023-075739
Organisation and delivery of supportive services for patients with prostate cancer in the National Health Service in England and Wales: a national cross-sectional hospital survey and latent class analysis
Joanna Dodkins, Adrian Cook, Melanie Morris, Julie Nossiter, Steve Prust, Steve Waller, Jan van der Meulen, Ajay Aggarwal, Noel Clarke, Heather Ann Payne

BMJ Open Nov 2023, 13 (11) e071674; DOI: 10.1136/bmjopen-2023-071674
Danish Prostate Cancer Consortium Study 1 (DPCC-1) protocol: Multicentre prospective validation of the urine-based three-microRNA biomarker model uCaP
Jacob Fredsøe, Eske Glud, Lars Boesen, Vibeke Løgager, Mads Hvid Poulsen, Bodil Ginnerup Pedersen, Michael Borre, Karina Dalsgaard Sørensen

BMJ Open Nov 2023, 13 (11) e077020; DOI: 10.1136/bmjopen-2023-077020

Main menu

Prostate Disease

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Prostate Disease

Pages